Related Experiment Video
Updated: Jun 13, 2026
Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation
Published on: July 8, 2011
Optimized protocols for siRNA delivery into monocytes and dendritic cells
Anne Mobergslien1, Mouldy Sioud
1Departments of Immunology, Institute for Cancer Research, Radiumhospitalet-Rikshopitalet University Hospital, Oslo, Norway.
Abstract:
Over the past decade, immunotherapy has emerged as a promising alternative form of cancer treatment with the potential to eradicate tumour metastasis. Unfortunately, its curative potential is in general limited by immunosuppressive proteins that negatively regulate dendritic (DC) and/or T-cell function. The recent discovery of RNA interference (RNAi) has facilitated the study of gene function in immune cells and recent data indicate that DC maturation, function, and survival can be modulated by small interfering RNAs (siRNAs) targeting genes involved in immune suppression. This chapter describes detailed protocols for introducing siRNAs into human monocytes and dendritic cells using standard electroporation techniques.
Insights
Immunotherapy shows promise for cancer treatment but is hindered by immunosuppressive proteins. RNA interference (RNAi) using small interfering RNAs (siRNAs) can modulate immune cells, offering a new strategy to enhance cancer immunotherapy.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- Immunotherapy is a promising cancer treatment, but its effectiveness is limited by immunosuppressive proteins that impair dendritic cell (DC) and T-cell functions.
- RNA interference (RNAi) offers a method to study gene function in immune cells.
- Small interfering RNAs (siRNAs) can modulate DC maturation, function, and survival by targeting immune-suppressing genes.
Purpose of the Study:
- To describe protocols for introducing siRNAs into human monocytes and DCs.
- To explore the potential of RNAi to overcome immune suppression in cancer immunotherapy.
Main Methods:
- Utilizing RNA interference (RNAi) with small interfering RNAs (siRNAs).
- Employing standard electroporation techniques.
- Introducing siRNAs into human monocytes and dendritic cells (DCs).
Main Results:
- Protocols for siRNA delivery into human monocytes and DCs are detailed.
- Demonstrates the feasibility of using siRNA to target genes involved in immune suppression within DCs.
Conclusions:
- siRNA delivery via electroporation is a viable method for modulating human monocytes and DCs.
- This technique holds potential for enhancing cancer immunotherapy by overcoming immune suppression.
